Ontology highlight
ABSTRACT:
SUBMITTER: Fleming KA
PROVIDER: S-EPMC6174881 | biostudies-literature | 2018 Sep
REPOSITORIES: biostudies-literature
Fleming Katlyn A KA Freeman Katie T KT Ericson Mark D MD Haskell-Luevano Carrie C
Journal of medicinal chemistry 20180816 17
Antagonist ligands of the melanocortin-3 and -4 receptors (MC3R, MC4R), including agouti-related protein (AGRP), are postulated to be targets for the treatment of diseases of negative energy balance. Previous studies reported the macrocyclic MC3R/MC4R antagonist c[Pro<sup>1</sup>-Arg<sup>2</sup>-Phe<sup>3</sup>-Phe<sup>4</sup>-Asn<sup>5</sup>-Ala<sup>6</sup>-Phe<sup>7</sup>-dPro<sup>8</sup>], which is 250-fold less potent at the mouse (m) mMC3R and 3-fold less potent at the mMC4R than AGRP. Prev ...[more]